Long-term effects of fenretinide on retinal function

被引:26
作者
Decensi, A
Fontana, V
Fioretto, M
Rondanina, G
Torrisi, R
Orengo, MA
Costa, A
机构
[1] UNIV GENOA, INST OPHTHALMOL, GENOA, ITALY
[2] EUROPEAN INST ONCOL, FIRC, CHEMOPREVENT UNIT, MILAN, ITALY
关键词
retinoids; retinal effects; cancer prevention;
D O I
10.1016/S0959-8049(96)00351-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The long-term effects of the synthetic retinoid fenretinide (4-HPR) on retinal function were studied by electroretinogram (ERG) in 24 women treated for a median of 30.5 months and in 18 untreated controls belonging to a phase III intervention trial. The six outcome measures were: a wave implicit time, peak-to-peak amplitude and implicit time of b wave following both cone stimulation and maximal cone-rod stimulation in the dark-adapted eye. Multivariate analysis of covariance was applied to evaluate the joint effect on the whole set of ERG measures taking into account their inter-relationship. Predictive factors with a significant effect on ERG measures were: (1) a qualitative interaction between age and treatment duration and (2) the squared (parabolic) function of plasma retinol. Individually, the b wave implicit time following cone stimulation was the only ERG measure significantly influenced by the predictors, indicating a primary effect of 4-HPR on retinal photoreceptor sensitivity without significant alterations of the inner nuclear layer. Thus, in contrast to previous reports at higher dose, administration of 4-HPR at 200 mg/day seems to exert subtle alterations of retinal function as measured by ERG. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:80 / 84
页数:5
相关论文
共 31 条
[1]   INVITRO INTERACTION OF FENRETINIDE WITH PLASMA RETINOL-BINDING PROTEIN AND ITS FUNCTIONAL CONSEQUENCES [J].
BERNI, R ;
FORMELLI, F .
FEBS LETTERS, 1992, 308 (01) :43-45
[2]   RETINOIDS - IN-VITRO INTERACTION WITH RETINOL-BINDING PROTEIN AND INFLUENCE ON PLASMA RETINOL [J].
BERNI, R ;
CLERICI, M ;
MALPELI, G ;
CLERIS, L ;
FORMELLI, F .
FASEB JOURNAL, 1993, 7 (12) :1179-1184
[3]   VISUAL TOXICITY OF SYNTHETIC RETINOIDS [J].
BROWN, RD ;
GRATTAN, CEH .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1989, 73 (04) :286-288
[4]  
CHIESA F, 1992, ORAL ONCOL, V28B, P97
[5]  
COSTA A, 1994, CANCER RES, V54, pS2032
[6]  
COSTA A, 1992, SERONO SYM, V79, P69
[7]   FENRETINIDE DOES NOT BLOCK VISUAL PIGMENT FORMATION IN THE RAT [J].
CROUCH, RK ;
GOLETZ, P .
JOURNAL OF OCULAR PHARMACOLOGY, 1988, 4 (03) :253-257
[8]   EFFECT OF THE SYNTHETIC RETINOID FENRETINIDE ON DARK-ADAPTATION AND THE OCULAR SURFACE [J].
DECENSI, A ;
TORRISI, R ;
POLIZZI, A ;
GESI, R ;
BREZZO, V ;
ROLANDO, M ;
RONDANINA, G ;
ORENGO, MA ;
FORMELLI, F ;
COSTA, A .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (02) :105-110
[9]   PILOT-STUDY OF HIGH-DOSE FENRETINIDE AND VITAMIN-A SUPPLEMENTATION IN BLADDER-CANCER [J].
DECENSI, A ;
BRUNO, S ;
TORRISI, R ;
PARODI, S ;
POLIZZI, A .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) :1909-1910
[10]  
DEW SE, 1993, CANCER RES, V53, P2965